Low forms of cyclin E reduce breast cancer drug's effectiveness
Tuesday, February 9, 2010 - 14:21
in Health & Medicine
Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers report.